Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Appl Microbiol ; 135(4)2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38637309

RESUMO

AIMS: To monitor severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA contamination in vehicles operating in England during the pandemic, to better understand transmission risk of SARS-CoV-2 on public transport. METHODS AND RESULTS: We collected 1314 surface samples between December 2020 and April 2022 on trains and buses managed by five different transport operators. The presence of SARS-CoV-2 RNA was investigated through reverse transcription polymerase chain reaction (RT-PCR). SARS-CoV-2 RNA was found on 197 (15%) of the 1314 surfaces sampled, including seat head rests, handholds, and air extract grilles, but the levels of RNA recovered on those samples (median value of 23.4, interquartile range: 14.3-35.4, N gene copies per extraction) made the presence of infectious virus at the time of sampling extremely unlikely. However, detection rates varied over time with peaks broadly coinciding with times of high community transmission, when it was more likely that people infected with SARS-CoV-2 were travelling on public transport. CONCLUSION: During the pandemic, and as in other public spaces, low levels of SARS-CoV-2 RNA were found on surfaces associated with public transport.


Assuntos
COVID-19 , RNA Viral , SARS-CoV-2 , COVID-19/transmissão , COVID-19/virologia , COVID-19/epidemiologia , SARS-CoV-2/genética , SARS-CoV-2/isolamento & purificação , Inglaterra/epidemiologia , RNA Viral/genética , RNA Viral/análise , RNA Viral/isolamento & purificação , Humanos , Estudos Longitudinais , Veículos Automotores , Meios de Transporte
2.
Appl Environ Microbiol ; 89(3): e0174422, 2023 03 29.
Artigo em Inglês | MEDLINE | ID: mdl-36856438

RESUMO

The virucidal activity of the Zoono Z71 Microbe Shield surface sanitizer and protectant, a quaternary ammonium compound (QAC)-based antimicrobial coating that was used by the United Kingdom rail industry during the COVID-19 pandemic, was evaluated, using the bacteriophage ɸ6 as a surrogate for SARS-CoV-2. Immediately after application and in the absence of interfering substances, the product effectively reduced (>3 log10) the viability of ɸ6 on some materials that are typically used in rail carriages (stainless steel, high-pressure laminate, plastic). If, after the application of the product, these surfaces remained undisturbed, the antimicrobial coating retained its efficacy for at least 28 days. However, efficacy depended on the material being coated. The product provided inconsistent results when applied to glass surfaces and was ineffective (i.e., achieved <3 log10 reduction) when applied to a train arm rest that was made of Terluran 22. Regardless of the material that was coated or the time since application, the presence of organic debris (fetal bovine serum) significantly reduced the viricidal activity of the coating. Wiping the surface with a wetted cloth after the deposition of organic debris was not sufficient to restore efficacy. We conclude that the product is likely to be of limited effectiveness in a busy, multiuser environment, such as public transport. IMPORTANCE This study evaluated the performance of a commercially available antimicrobial coating that was used by the transport industry in the United Kingdom during the COVID-19 pandemic. While the product was effective against ɸ6, the efficacy of the coating depended upon the material to which it was applied. Similarly, and regardless of the surface material, the presence of organic debris severely impaired viricidal activity, and efficacy could not be recovered through wiping (cleaning) the surface. This highlights the importance of including relevant materials and conditions when evaluating antimicrobial coatings in the laboratory. Further efforts are required to identify suitable infection prevention and control practices for the transport industry.


Assuntos
Anti-Infecciosos , COVID-19 , Humanos , COVID-19/prevenção & controle , SARS-CoV-2 , Compostos de Amônio Quaternário/farmacologia , Pandemias/prevenção & controle , Anti-Infecciosos/farmacologia , Anti-Infecciosos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...